Paper-based dosing algorithms for maintenance of warfarin anticoagulation

Journal of Thrombosis and Thrombolysis

Volumn 23, Issue 3, 2007, Pages 195-198

  Wilson, Sarah E ^a   Costantini, Lorrie ^b   Crowther, Mark A ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c ST JOSEPH S HOSPITAL   (Canada)

Author keywords

Algorithms; Oral anticoagulants; Warfarin

Indexed keywords

WARFARIN;

ADULT; AGED; ALGORITHM; ANTICOAGULATION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FOLLOW UP; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; PATIENT CARE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOSIS; TIME;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; ANTICOAGULANTS; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; TREATMENT OUTCOME; WARFARIN;

EID: 34147150248     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-006-9025-4     Document Type: Article

References (14)

1. Samsa GP, Matchar DB, Goldstein LB et al (2000) Quality of anticoagulation management among patients with atrial fibrillation: results of a review of medical records from 2 communities. Arch Med Res 160:967-973
2. McMahan DA, Smith DM, Carey MA, Zhou XH (1998) Risk of major hemorrhage for outpatient treatment with warfarin. J Gen Intern Med 13:311-316
3. Ansell J, Hirsh J, Poller L et al (2004) The pharmacology and management of the vitamin K antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126:204S-233S
4. Dalere GM, Coleman RW, Lum BL (1999) A graphic nomogram for warfarin dosage adjustment. Pharmacother 19:461-467
5. Fredriks DA, Coleman RW (1991) Nomogram for dosing warfarin at steady state. Clin Pharm 10:923-927
6. Crowther MA, Ginsberg JS, Julian J et al (2003) A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. NEJM 349:1133-1138
7. Wilson S, Crowther M, Costantini L (1999) An interim analysis to improve precision of warfarin anticoagulation control in a randomized clinical trial. Blood 94:10(S1)-115b
8. Rosendaal FR, Cannegeiter SC, van der Meer FJM et al (1993) A method to determine the optimal intensity of oral anticoagulation therapy. Thromb Haemost 69:236-239
9. Sawicki PT (1999) A structured teaching and self-management program for patient receiving oral anticoagulation: A randomized controlled trial; Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA 281:145-150
10. Wilson SJ, Wells PS, Kovacs MJ et al (2003) Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: A randomized controlled trial. CMAJ 169:293-298
11. Hellemons BSP, Langenberg M, Lodder J et al (1999) Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: Randomized controlled trial comparing two intensities of coumarin with aspirin. BMJ 319:958-964
12. Hurlen M, Abdelnoor M, Smith P et al (2002) Warfarin, aspirin, or both after myocardial infarction. NEJM 347:969-974
13. Kovacs M, Cruickshank M, Wells PS et al (1999) Randomized assessment of a warfarin nomogram for initial oral anticoagulation after venous thromboembolic disease. Haemostasis 28:62-68
14. Gedge J, Orme S, Hampton KK, Channer KS, Hendra TJ (2000) A comparison of a warfarin induction regimen with the modified Fennerty regimen in elderly inpatients. Age Ageing 29:31-34